A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer

Gynecologic Oncology

Volumn 100, Issue 3, 2006, Pages 506-510

  Six, Lucia ^a   Grimm, Christoph ^a   Leodolter, Sepp ^a,b   Tempfer, Clemens ^a,b   Zeillinger, Robert ^a,b   Sliutz, Gerhard ^a   Speiser, Paul ^a   Reinthaller, Alexander ^a   Hefler, Lukas A ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Gene; MMP 1; Ovarian cancer; Polymorphism

Indexed keywords

INTERSTITIAL COLLAGENASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CONTROLLED STUDY; DISEASE FREE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; GENETIC CORRELATION; GENETIC POLYMORPHISM; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION;

FEMALE; HUMANS; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS (GENETICS);

EID: 32644487779     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.049     Document Type: Article

References (34)

1. S. Ye Polymorphism in matrix metalloproteinase gene promotors: implication in regulation of gene expression and susceptibility of various diseases Matrix Biol. 19 2000 623 629
2. J. Zhang, X. Jin, S. Fang, R. Wang, Y. Li, and N. Wang The functional polymorphism in the matrix metalloproteinase-7 promotor increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma Carcinogenesis 2005 (Jun 1)
3. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Cancer 2 2002 163 176
4. Z. Werb ECM and cell surface proteolysis: regulating cellular ecology Cell 91 1997 439 442
5. M.E. Lukashew, and Z. Werb ECM signaling: orchestrating cell behaviour and misbehaviour Trends Cell Biol. 8 1998 437 441
6. L.M. Coussens, and Z. Werb Matrix metalloproteinases and the development of cancer Chem. Biol. 3 1996 895 904
7. S.H. Barsky, G.P. Siegal, F. Jannotta, and L.A. Liotta Loss of basement membrane components by invasive tumors but not by their benign counterparts Lab. Invest. 49 1983 140 147
8. L.A. Liotta, K. Tryggvason, S. Garbisa, I. Hart, C.M. Foltz, and S. Shafie Metastic potential correlates with enzymatic degradation of basement membrane collagen Nature (London) 284 1980 67 68
9. R.F. Jacoby, S. Schlack, C.E. Cole, M. Sharbek, C. Harris, and L.F. Meisner A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria Gastroenterology 112 1997 1398 1403
10. J.R. Howe, S. Roth, J.C. Ringold, R.W. Summers, H.J. Jarvinen, and P. Sistonen Mutations in the SMAD4/DPC4 gene in juvenile polyposis Science (Washington DC) 280 1998 1086 1088
11. C.J. Hsieh, B. Klump, K. Holzmann, F. Borchard, M. Gregor, and R. Porschen Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis Cancer Res. 58 1998 3942 3945
12. T.W. Jacobs, C. Byme, G. Colditz, J.L. Connolly, and S.J. Schnitt Radial scars in benign breast-biopsy specimens and the risk of breast cancer N. Engl. J. Med. 340 1999 430 436
13. R.E. Hewitt, I.H. Leach, D.G. Powe, I.M. Clark, T.E. Cawston, and D.R. Turner Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumors Int. J. Cancer 49 1991 666 672
14. A.F. Chambers, and L.M. Matrisian Changing views of the role of matrix metalloproteinases in metastasis J. Natl. Cancer Inst. (Bethesda) 89 1997 1260 1270
15. G.I. Murray, M.E. Duncan, P. O'Neil, W.T. Melvin, and J.E. Fothergill Matrix metalloproteinases-1 is associated with poor prognosis in colorectal cancer Nat. Med. 2 1996 461 462
16. GI. Murray, M.E. Duncan, P. O'Neil, J.A. McKay, W.T. Melvin, and J.E. Fothergill Matrix metalloproteinases-1 is associated with poor prognosis in oesophageal cancer J. Pathol. 185 1998 256 261
17. G. Buttice, M. Duterque-Coquillaud, J.P. Basuyaux, S. Carrere, M. Kurkinen, and D. Stehelin Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex Oncogene 13 1996 2297 2306
18. J.L. Rutter, T.I. Mitchell, G. Buttice, J. Meyers, J.F. Gusella, and L.J. Ozelius A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription Cancer Res. 58 1998 5321 5325
19. Y. Kanamori, M. Matsushima, T. Minagushi, K. Kobayashi, S. Sagae, and R. Kudo Correlation between expression of the matrix Metalloproteinase-1 Gene in ovarian cancers and an insertion/deletion polymorphism in its promotor region Cancer Res. 59 17 1999 4225 4227
20. R.M. Wenham, B. Calingaert, S. Ali, K. McClean, R. Whitaker, and R. Bentley Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer J. Soc. Gynecol. Invest. 10 6 2003 381 387
21. F. Zinzindohoue, T. Lecomte, J.M. Ferraz, A.M. Houllier, P.H. Cugnenc, and A. Berger Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer Clin. Cancer Res. 11 2005 594 599
22. S. Curran, S.R. Dundas, J. Buxton, M.F. Leeman, R. Ramsay, and G.I. Murray Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers Clin. Cancer Res. 10 2004 8229 8234
23. H.C. Lai, C.M. Chu, Y.W. Lin, C.C. Chang, S. Nieh, and M.H. Yu Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer Gynecol. Oncol. 96 2 2005 314 319
24. L. Hefler, C. Grimm, S. Ackermann, S. Malur, A. Radjabi-Rahat, and S. Leodolter An interleukin-6 gene promotor polymorphism influences the biological phenotype of ovarian cancer Cancer Res. 63 12 2003 3066 3068
25. H. Hirata, N. Okayama, K. Naito, R. Inoue, S. Yoshihiro, and H. Matsuyama Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma Carcinogenesis 25 12 2004 2379 2384
26. G. Ghilardi, M.L. Biondi, J. Mangoni, S. Leviti, M. DeMonti, and E. Guagnellini Matrix metalloproteinase-1 promotor polymorphism 1G/2G is correlated with colorectal cancer invasiveness Clin. Cancer Res. 7 8 2001 2344 2346
27. J. Zhu, M.R. Spitz, L. Lei, G.B. Mills, and X. Wu A single polymorphism in the matrix metalloproeinase-1 promotor enhances lung cancer susceptibility Cancer Res. 61 21 2001 7825 7829
28. C. Tempfer, A. Obermair, G. Haeusler, G. Gitsch, and C. Kainz Vascular endothelial growth factor serum concentrations in ovarian cancer Obstet. Gynecol. 92 3 1998 360 363
29. L.A. Hefler, E. Ludwig, D. Lampe, R. Zeillinger, S. Leodolter, and G. Gitsch Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer Gynecol. Oncol. 86 2 2002 134 137
30. I. Cass, R.L. Baldwin, T. Varkey, R. Moslehi, S.A. Narod, and B.Y. Karlan Improved survival in women with BRCA-associated ovarian carcinoma Cancer 97 9 2003 2187 2195
31. P.L. Moser, D.G. Kieback, L. Hefler, C. Tempfer, W. Neunteufel, and G. Gitsch Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer Anticancer Res. 19 5C 1999 4391 4393
32. O. Brummer, G. Bohmer, B. Hollwitz, P. Flemming, K.U. Petry, and H. Kuhnle MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation-an immunohistochemical study Gynecol. Oncol. 84 2 2002 222 227
33. A. Nishikawa, M. Iwasaki, N. Akutagawa, K. Manase, S. Yamashita, and T. Endo Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential Gynecol. Oncol. 79 2 2000 256 263
34. K. Przybylowska, J. Zielinska, M. Zadrozny, T. Krawczyk, A. Kulig, and P. Wozniak An association between the matrix metalloproteinase-1 promoter gene polymorphism and lymphnode metastasis in breast cancer J. Exp. Clin. Cancer Res. 23 1 2004 121 125